NO20072004L - Substituerte kromanderivater, medikamenter og anvendelse i terapi - Google Patents
Substituerte kromanderivater, medikamenter og anvendelse i terapiInfo
- Publication number
- NO20072004L NO20072004L NO20072004A NO20072004A NO20072004L NO 20072004 L NO20072004 L NO 20072004L NO 20072004 A NO20072004 A NO 20072004A NO 20072004 A NO20072004 A NO 20072004A NO 20072004 L NO20072004 L NO 20072004L
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- therapy
- chroman derivatives
- substituted chroman
- substituted
- Prior art date
Links
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Chemical class 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61130004P | 2004-09-21 | 2004-09-21 | |
PCT/AU2004/001619 WO2005049008A1 (en) | 2003-11-19 | 2004-11-19 | Combinational radiotherapy and chemotherapy compositions and methods |
AU2005201855A AU2005201855B2 (en) | 2004-09-21 | 2005-05-03 | Chroman derived compounds and formulations thereof for use in therapy |
PCT/AU2005/001435 WO2006032085A1 (en) | 2004-09-21 | 2005-09-21 | Substituted chroman derivatives, medicaments and use in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072004L true NO20072004L (no) | 2007-05-30 |
Family
ID=36089770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072004A NO20072004L (no) | 2004-09-21 | 2007-04-19 | Substituerte kromanderivater, medikamenter og anvendelse i terapi |
Country Status (11)
Country | Link |
---|---|
US (6) | US7601855B2 (de) |
EP (2) | EP2407462B1 (de) |
CN (1) | CN101056868B (de) |
AT (1) | ATE532777T1 (de) |
AU (1) | AU2005287865B2 (de) |
CA (1) | CA2581316C (de) |
IL (1) | IL182034A (de) |
MX (1) | MX2007003216A (de) |
NO (1) | NO20072004L (de) |
NZ (1) | NZ553834A (de) |
WO (1) | WO2006032085A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
US8080675B2 (en) * | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
JP2008533177A (ja) * | 2005-03-24 | 2008-08-21 | ノボジェン リサーチ ピーティーワイ リミテッド | 抗炎症治療法 |
AU2008229617A1 (en) * | 2007-03-16 | 2008-09-25 | Novogen Research Pty Ltd | Method for inducing autophagy |
CA2738328A1 (en) * | 2008-08-29 | 2010-03-04 | Novogen Research Pty Ltd | Immunomodulating activities |
CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US20120251630A1 (en) * | 2011-03-29 | 2012-10-04 | Marshall Edwards, Inc. | Remission therapy of cancer with isoflavonoids |
US8911935B2 (en) | 2011-10-17 | 2014-12-16 | New York University | Mitochondria and human immunodefiency virus type 1 |
KR101459195B1 (ko) | 2012-12-28 | 2014-11-07 | 경기대학교 산학협력단 | 항암 활성을 갖는 4-니트로알킬크로만 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물 |
EP2953938B1 (de) | 2014-02-07 | 2017-08-02 | Novogen Ltd. | Funktionalisierte benzopyranverbindungen und verwendung davon |
AU2016215515B2 (en) | 2015-02-02 | 2020-04-30 | Mei Pharma, Inc. | Combination therapies |
AU2017247006B2 (en) * | 2016-04-06 | 2022-05-12 | Noxopharm Limited | Radiotherapy improvements |
AU2017247008B2 (en) | 2016-04-06 | 2022-04-07 | Noxopharm Limited | Isoflavonoid composition with improved pharmacokinetics |
JP2023519990A (ja) | 2020-03-30 | 2023-05-15 | ノクソファーム リミティド | 感染に関連する炎症の治療のための方法 |
WO2023090829A1 (ko) * | 2021-11-17 | 2023-05-25 | 엘젠테라퓨틱스 주식회사 | Mll1-wdr5 상호작용을 조절하는 저분자 화합물 및 이의 용도 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1518002C3 (de) * | 1965-01-02 | 1975-01-23 | Merck Patent Gmbh, 6100 Darmstadt | Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel |
DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
GB1433013A (de) | 1973-06-08 | 1976-04-22 | ||
US4264509A (en) | 1977-06-08 | 1981-04-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4157984A (en) * | 1977-06-08 | 1979-06-12 | Z-L Limited | Antioxidants, antioxidant compositions and methods of preparing and using same |
US4218489A (en) * | 1977-06-08 | 1980-08-19 | Z-L Limited Partnership | Antioxidants, antioxidant compositions and methods of preparing and using same |
US4232122A (en) * | 1979-01-17 | 1980-11-04 | Z-L Limited Partnership | Antioxidants, antioxidant compositions and methods of preparing and using same |
US4234577A (en) * | 1979-03-19 | 1980-11-18 | Z-L Limited Partnership | Ergostadientriols, compositions containing same, and methods of preparing and using same |
US4368264A (en) * | 1979-03-19 | 1983-01-11 | Z-L Limited Partnership | Fermentation methods of preparing ergostadientriols |
US4366248A (en) * | 1979-04-11 | 1982-12-28 | Z-L Limited Partnership | Fermentation method of preparing antioxidants |
US4366082A (en) * | 1979-04-11 | 1982-12-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4390559A (en) * | 1979-04-11 | 1983-06-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US4447622A (en) * | 1981-09-22 | 1984-05-08 | Council Of Scientific And Industrial Research Rafi Marg | Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof |
US4644012A (en) | 1983-12-21 | 1987-02-17 | Takeda Chemical Industries, Ltd. | Treatment for osteoporosis |
GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
MX13485A (es) | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
EP0470310B1 (de) | 1990-08-09 | 1995-11-29 | Council of Scientific and Industrial Research | Benzopyrane und Verfahren zu deren Herstellung |
KR950704291A (ko) | 1992-10-21 | 1995-11-17 | 알렌 제이. 스피겔 | 거울상 이성질체 시스-3-(4,6-디하이드록시크로만-3-일메틸)벤조산(enantiomeric cis-3-(4,6-dihydroxychroman-3-ylmethyl)benzoic acids) |
US5451603A (en) | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
US5389646A (en) * | 1993-12-30 | 1995-02-14 | Zymogenetics, Inc. | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
US5792776A (en) | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
HUP9702244A3 (en) | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
CA2208859A1 (en) | 1995-01-13 | 1996-07-18 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
WO1996021442A1 (en) | 1995-01-13 | 1996-07-18 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia |
TW448046B (en) | 1995-01-20 | 2001-08-01 | Novo Nordisk As | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
CA2208856A1 (en) | 1995-01-20 | 1996-07-25 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
JPH10513154A (ja) | 1995-01-20 | 1998-12-15 | ノボ ノルディスク アクティーゼルスカブ | 血管拡張治療または予防用の医薬組成物の製造への3,4−ジフェニルクロマンの使用 |
US5849461A (en) * | 1995-08-01 | 1998-12-15 | Shin-Etsu Chemical Co., Ltd. | Chemically amplified positive resist composition |
US5883118A (en) | 1996-01-11 | 1999-03-16 | Nova Nordisk A/S | Prostatic carcinoma |
US5747059A (en) | 1996-01-11 | 1998-05-05 | Novo Nordisk A/S | Atrophy of skin/mucous membrane |
HUP9902683A3 (en) | 1996-01-11 | 2001-08-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms |
US5726202A (en) | 1996-01-11 | 1998-03-10 | Novo Nordisk A/S | Benign prostatic hypertrophy |
US5756539A (en) * | 1996-07-11 | 1998-05-26 | Novo Nordis A/S | 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders |
EP0921797A1 (de) | 1996-07-12 | 1999-06-16 | Novo Nordisk A/S | Verwendung von 3,4-diphenyl cromane in pharmazeutischen zusammensetzungen zur senkung des augeninnendruckes |
JP2000514441A (ja) | 1996-07-12 | 2000-10-31 | ノボ ノルディスク アクティーゼルスカブ | 月経前症候群の1又は複数の症状を抑制するための医薬組成物の製造のための3,4―ジフェニルクロマンの使用 |
US5780502A (en) * | 1996-07-12 | 1998-07-14 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
GB9621757D0 (en) | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
JP2001502706A (ja) | 1996-10-28 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―3,4クロマン誘導体 |
US5994390A (en) * | 1996-10-28 | 1999-11-30 | Novo Nordisk | Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US6043269A (en) * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
ATE231141T1 (de) | 1996-10-28 | 2003-02-15 | Novo Nordisk As | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen |
US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
US5958967A (en) * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
ZA979647B (en) | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. |
AU4699997A (en) | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
ZA979644B (en) | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. |
US5919817A (en) * | 1996-10-28 | 1999-07-06 | Novo Nordisk A/S | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
IL129618A0 (en) | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
CA2270113A1 (en) * | 1996-10-28 | 1998-05-07 | Poul Jacobsen | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US6316494B1 (en) * | 1996-10-28 | 2001-11-13 | Novo Nordisk A/S | cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
WO1998018770A1 (en) | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | A process for the preparation of (-)-3,4-trans-diarylchromans |
IL129627A0 (en) | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
AU722089B2 (en) * | 1996-12-13 | 2000-07-20 | Chugai Seiyaku Kabushiki Kaisha | Novel benzopyran derivatives |
AU5550298A (en) | 1997-01-29 | 1998-08-25 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women |
AU5550398A (en) | 1997-01-29 | 1998-08-25 | Novo Nordisk A/S | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting senescence-associated motor impairment |
ZA98682B (en) | 1997-01-29 | 1998-07-29 | Novo Nordisk As | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders |
AU3456499A (en) | 1998-03-30 | 1999-10-18 | University Of Mississippi, The | Isoflavones for treating giardiasis and malaria |
EP1073762A1 (de) | 1998-04-28 | 2001-02-07 | Novo Nordisk A/S | Enzymatische auflosung zur gewinnung von (-)-3,4,-trans-diarylchroman |
FR2778404B1 (fr) | 1998-05-06 | 2000-06-30 | Hoechst Marion Roussel Inc | Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
KR20000001793A (ko) * | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 |
AUPP868599A0 (en) | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
AUPQ008299A0 (en) | 1999-04-30 | 1999-05-27 | G.J. Consultants Pty Ltd | Isoflavone metabolites |
AUPQ266199A0 (en) | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AU7896100A (en) | 1999-10-14 | 2001-04-23 | Endorecherche Inc. | Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance |
AU1888001A (en) * | 1999-12-13 | 2001-06-18 | Chugai Seiyaku Kabushiki Kaisha | Optically active chroman and thiochroman derivatives |
PL357163A1 (en) | 2000-01-28 | 2004-07-26 | Endorecherche, Inc. | Selective estrogen receptor modulators in combination with estrogens |
FI20001593A (fi) | 2000-07-03 | 2002-01-04 | Orion Yhtymo Oyj | Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia |
DK1355906T3 (da) * | 2001-01-24 | 2005-05-30 | Chiesi Farma Spa | 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem |
HUP0500573A2 (hu) | 2001-08-11 | 2005-11-28 | Bristol-Myers Squibb Pharma Company | Trifenil-etilén származékok, mint szelektív ösztrogén receptor modulátorok és ezeket tartalmazó gyógyszerkészítmények |
AUPR846401A0 (en) | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
WO2003063859A1 (en) * | 2002-01-14 | 2003-08-07 | Nordic Bioscience A/S | Suppression of cartilage degradation via the estrogen receptor |
CA2478392A1 (en) | 2002-04-09 | 2003-10-23 | Novogen Research Pty Ltd | Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
AU2002951833A0 (en) | 2002-10-02 | 2002-10-24 | Novogen Research Pty Ltd | Compositions and therapeutic methods invloving platinum complexes |
EP1686981A4 (de) * | 2003-11-19 | 2011-02-23 | Novogen Res Pty Ltd | Zusammensetzungen und verfahren für die kombinierte strahlentherapie und chemotherapie |
ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
JP4976649B2 (ja) | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ,インク. | 化合物 |
EP1809618B1 (de) | 2004-09-21 | 2013-07-17 | Marshall Edwards, Inc. | Chromanderivate, medikamente und anwendung in der therapie |
US8080675B2 (en) * | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
AU2008229617A1 (en) | 2007-03-16 | 2008-09-25 | Novogen Research Pty Ltd | Method for inducing autophagy |
CA2738328A1 (en) | 2008-08-29 | 2010-03-04 | Novogen Research Pty Ltd | Immunomodulating activities |
CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US20120251630A1 (en) | 2011-03-29 | 2012-10-04 | Marshall Edwards, Inc. | Remission therapy of cancer with isoflavonoids |
-
2005
- 2005-09-21 AT AT05779877T patent/ATE532777T1/de active
- 2005-09-21 CN CN2005800381178A patent/CN101056868B/zh active Active
- 2005-09-21 EP EP20110175917 patent/EP2407462B1/de not_active Not-in-force
- 2005-09-21 WO PCT/AU2005/001435 patent/WO2006032085A1/en active Application Filing
- 2005-09-21 MX MX2007003216A patent/MX2007003216A/es active IP Right Grant
- 2005-09-21 EP EP05779877A patent/EP1794141B1/de active Active
- 2005-09-21 CA CA2581316A patent/CA2581316C/en active Active
- 2005-09-21 US US11/230,726 patent/US7601855B2/en active Active
- 2005-09-21 NZ NZ553834A patent/NZ553834A/en not_active IP Right Cessation
- 2005-09-21 AU AU2005287865A patent/AU2005287865B2/en active Active
-
2007
- 2007-03-20 IL IL182034A patent/IL182034A/en active IP Right Grant
- 2007-04-19 NO NO20072004A patent/NO20072004L/no not_active Application Discontinuation
-
2009
- 2009-08-31 US US12/551,277 patent/US8084628B2/en active Active
-
2011
- 2011-11-10 US US13/293,947 patent/US8697891B2/en not_active Expired - Fee Related
-
2014
- 2014-02-21 US US14/186,940 patent/US9138478B2/en not_active Expired - Fee Related
-
2015
- 2015-08-18 US US14/829,507 patent/US9381186B2/en not_active Expired - Fee Related
-
2016
- 2016-06-07 US US15/175,386 patent/US20160287555A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150352074A1 (en) | 2015-12-10 |
US20160287555A1 (en) | 2016-10-06 |
NZ553834A (en) | 2010-03-26 |
AU2005287865A1 (en) | 2006-03-30 |
US8084628B2 (en) | 2011-12-27 |
IL182034A (en) | 2012-10-31 |
IL182034A0 (en) | 2007-07-24 |
EP1794141B1 (de) | 2011-11-09 |
EP1794141A4 (de) | 2009-05-27 |
US20120114766A1 (en) | 2012-05-10 |
MX2007003216A (es) | 2008-03-10 |
US9138478B2 (en) | 2015-09-22 |
EP2407462B1 (de) | 2014-07-30 |
CA2581316C (en) | 2013-09-10 |
EP2407462A1 (de) | 2012-01-18 |
US20060074127A1 (en) | 2006-04-06 |
CN101056868B (zh) | 2012-05-02 |
CA2581316A1 (en) | 2006-03-30 |
US20140170243A1 (en) | 2014-06-19 |
EP1794141A1 (de) | 2007-06-13 |
WO2006032085A1 (en) | 2006-03-30 |
US7601855B2 (en) | 2009-10-13 |
AU2005287865B2 (en) | 2012-02-16 |
US9381186B2 (en) | 2016-07-05 |
ATE532777T1 (de) | 2011-11-15 |
US8697891B2 (en) | 2014-04-15 |
CN101056868A (zh) | 2007-10-17 |
US20090317490A1 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072004L (no) | Substituerte kromanderivater, medikamenter og anvendelse i terapi | |
EP2436680A3 (de) | Chromanderivate, Medikamente und Anwendung in der Therapie | |
DK1951729T3 (da) | Oxygenbundne pyrimidinderivater | |
SE0301700D0 (sv) | Novel compounds | |
CY1116372T1 (el) | Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη | |
IL184051A (en) | Acetylated GLP-1 compounds, containing and using pharmaceutical preparations | |
DK1730131T3 (da) | Glucopyranosyl-substituerede benzol-derivater, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåder til deres fremstilling | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
ATE380807T1 (de) | N-oxid von n-phenyl-2-pyrimidinaminderivaten | |
GEP20115231B (en) | 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones | |
ATE472551T1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
DE602005006815D1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
SE0401971D0 (sv) | Piperidne derivatives | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
CY1111833T1 (el) | Διμερη παραγωγων αρτεμισινινης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
DE602005011818D1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
SE0300457D0 (sv) | Novel compounds | |
SV2008002856A (es) | 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas | |
WO2005097757A3 (en) | Nucleoside derivatives and therapeutic use thereof | |
DK1742947T3 (da) | 6-substituerede pyridoindolanderivater, fremstilling og terapeutisk anvendelse heraf | |
DE602005010725D1 (de) | Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür | |
NO20071578L (no) | Kromanderivater, legemidler og anvendelse i terapi | |
DK1708693T3 (da) | Farmaceutiske sammensætninger indeholdende platinkomplekser med sekundære xanthater og terapeutiske anvendelser deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |